Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 30, 2024 | (FY)Dec 30, 2023 | (FY)Dec 30, 2022 | (FY)Dec 30, 2021 | |
|---|---|---|---|---|
| Total revenue | -65.03%5.15M | 10.18%14.74M | 58.26%13.38M | 8.45M |
| Operating revenue | -65.03%5.15M | 10.18%14.74M | 58.26%13.38M | --8.45M |
| Cost of revenue | -62.67%2.55M | 5.43%6.82M | 40.59%6.47M | 4.6M |
| Gross profit | -67.06%2.61M | 14.64%7.91M | 79.39%6.9M | 3.85M |
| Operating expense | -51.47%9.36M | -14.83%19.28M | 59.52%22.63M | 14.19M |
| Selling and administrative expenses | -51.47%9.36M | -14.83%19.28M | 70.57%22.63M | --13.27M |
| -Selling and marketing expense | -55.69%4.45M | -25.91%10.05M | 94.30%13.56M | --6.98M |
| -General and administrative expense | -46.86%4.9M | 1.73%9.23M | 44.24%9.07M | --6.29M |
| Depreciation amortization depletion | ---- | ---- | ---- | --4.6K |
| -Depreciation and amortization | ---- | ---- | ---- | --4.6K |
| Other operating expenses | ---- | ---- | ---- | --914.97K |
| Operating profit | 40.61%-6.75M | 27.76%-11.36M | -52.12%-15.73M | -10.34M |
| Net non-operating interest income (expenses) | -200.57%-2.84M | -603.88%-943.64K | 97.33%-134.06K | -5.02M |
| Non-operating interest income | ---- | ---- | -94.27%7.3497 | --128.2916 |
| Non-operating interest expense | 200.57%2.84M | 603.84%943.64K | -97.33%134.07K | --5.02M |
| Other net income (expenses) | 11.07%460.38K | 51.76%414.5K | -85.96%273.14K | 1.95M |
| Other non-operating income (expenses) | 11.07%460.38K | 51.76%414.5K | -85.96%273.14K | --1.95M |
| Income before tax | 23.27%-9.13M | 23.73%-11.89M | -26.06%-15.59M | -12.37M |
| Income tax | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||
| Net income | 136.07%4.29M | 23.73%-11.89M | -26.06%-15.59M | -12.37M |
| Net income continuous operations | 23.27%-9.13M | 23.73%-11.89M | -26.06%-15.59M | ---12.37M |
| Net income discontinuous operations | --13.41M | ---- | ---- | ---- |
| Noncontrolling interests | ||||
| Net income attributable to the company | 136.07%4.29M | 23.73%-11.89M | -26.06%-15.59M | -12.37M |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | ||||
| Net income attributable to common stockholders | 136.07%4.29M | 23.73%-11.89M | -26.06%-15.59M | -12.37M |
| Diluted earnings per share | 132.94%0.0148 | 51.66%-0.0449 | -2.47%-0.0929 | -0.0907 |
| Basic earnings per share | 132.94%0.0148 | 51.66%-0.0449 | -2.47%-0.0929 | -0.0907 |
| Dividend per share | ||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |